展望2019:寻求中国生物医药企业生存与发展的新平衡点

2019 Outlook: Find a New Balance between Survival and Development of China's Biopharmaceutical Industry

2018年是中国生物医药趋于理性发展的一年。2019年,在政策、经济环境的变化之下,制药企业将进入新的调整期。上海市药物研发协同创新中心召开智库圆桌会议,通过多轮头脑风暴,对我国生物医药行业进行了年度展望,提出生物医药企业需在生存与发展之间找到合适的新平衡点。

2018 witnessed the rational development of China’s biopharmaceutical industry.In 2019,with the changes in political and economic environment,biopharmaceutical enterprises will enter a new period of adjustment.At the beginning of 2019,Shanghai Center for Innovation Drug Discovery and Development(SCIDDD)held a series of roundtable brainstorming,and proposed the 2019 outlook of China’s biopharmaceutical industry,emphasizing that biopharmaceutical enterprises need to find a new balance between survival and development.